March, 26 2026 Thursday 19:02 Hrs
Last update 11-9-2025
  • SENSEX :   75,273.45

  • Commodity broking firm in India1,205.00( 1.63%) 25-Mar-2026
top-arrow-market
Sensex 75273.45 1205.00  (1.63) 25-Mar-2026
Previous Day Close
74068.45
Today's High/Low
High Low
  •  
  •  
75849.76 74550.47

Company News Details

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
461.79599
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
11.63
17440.82
EPS(TTM)
Face Value()
Div & Yield %
83.75
2
0.62
 

Natco Pharma receives USFDA EIR report for API unit in Chennai
Feb 13,2026
NATCO Pharma announced that the U.S. Food and Drug Administration (FDA) had conducted an inspection at the Active Pharmaceutical Ingredient Division located in Manali, Chennai from 17 November – 21 November 2025. The Company received seven (7) observation in the Form-483.

Further, the Company has received the EIR (Establishment Inspection Report) from the USFDA on the classification of the above-referred inspection as Voluntary Action Indicated (VAI).

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.